AbbVie Inc. reports results for the quarter ended September 30 - Earnings Summary

What happened

AbbVie reported quarterly adjusted earnings of $3.82 per share, beating the $3.75 average analyst estimate. Revenue rose 10.3% to $17.40 billion, above the expected $17.31 billion. Reported earnings per share were $2.37, with net income of $4.22 billion.

Confirmed

Global impact / market context

Higher revenue and adjusted profit than analysts expected suggest AbbVie sold more or controlled costs better than forecast. That supports cash available to fund research, dividends, and debt payments, and may justify the stock's 11.2% quarterly gain if the trend continues.

Analyst inference

Analysts had cut earnings estimates about 2.5% over three months, with eighteen negative revisions in thirty days, so results beat lowered expectations. The average rating is buy and the median $288 price target sits just below the $290.79 close, suggesting shares already reflect much optimism.

Analyst inference

What to watch

1. Analysts expect earnings between $3.61 and $3.84 per share; future results near the low end would signal weaker profit per sale than the $3.82 reported this quarter. Confirmed
2. Watch whether eighteen recent negative estimate revisions reverse after this beat, since upward revisions would suggest analysts see the profit gain as repeatable rather than one-off. Proposed
3. Watch whether the shares hold above the $288 median price target; a sustained move higher would show investors accept the strong quarter, while a drop could signal the beat was already priced in. Analyst inference

Evidence

• Original source link unavailable